There are 2789 resources available
284P - Trastuzumab emtansine (T-DM1) in Asian patients with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC): Data from the phase III EMILIA study
Presenter: Seock-Ah Im
Session: ePoster Display
285P - Real-world outcomes associated with pyrotinib-based therapy for HER2-positive metastatic breast cancer
Presenter: Li Hao
Session: ePoster Display
286P - Outcome of patients with HER2-positive brain metastatic breast cancer: A 10-year retrospective study
Presenter: Cecile Bigot
Session: ePoster Display
312P - Survival of breast cancer patients with brain metastases treated with radiotherapy in Ontario, Canada: A population-based study
Presenter: Rania Chehade
Session: ePoster Display
313P - Use of PARPi among patients with advanced breast cancer
Presenter: Shaheenah Dawood
Session: ePoster Display
314P - Efficacy of taxane rechallenge in early metastatic relapse of HER2-negative breast cancer patients previously treated with taxane
Presenter: Antoine Vasseur
Session: ePoster Display
315P - Treatment patterns in black and indigenous people and people of color (BIPOC) receiving palbociclib for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in a real-world setting: POLARIS study results
Presenter: Gabrielle Rocque
Session: ePoster Display
316P - Attitudes towards the use of stereotactic body radiation therapy in oligometastatic breast cancer: Results of an OncoAlert survey
Presenter: Petra Vukovic
Session: ePoster Display
317P - Survival analysis and prognostic factors in patients with metastatic breast cancer and oligometastatic disease
Presenter: Gema Marin Zafra
Session: ePoster Display
318P - Impact of right dose vs on-time chemotherapy on PFS in patients suffering from metastatic breast cancer
Presenter: Anudeep Padakanti
Session: ePoster Display